This treatment combined with HER2.CAR-T cells was able to control both primary and metastasized tumors in an orthotopic model of HNSCC causing lymph node metastasis similar to those seen in HNSCC patients. Here, ERBB2 is linked to head and neck squamous cell carcinoma.